Thalidomide in Oncology: the Peril and the Promise

Tseng S. , Pak G. , Washenik K. . Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses. J Am Acad Dermatol. 1996; 35: 969–979.

Argiles J.M. , Carbo N. , Lopez-Soriano F.J. . Was tumor necrosis factor alpha responsible for the fetal malformations associated with thalidomide in the early 1960s? Med Hypotheses , 1998; 50: 313–318.

Thalomid capsules (thalidomide) prescription product insert. Warren, NJ: Celgene Corp; revised August 1998.

Vogelsang G.B. , Taylor S. , Gordon G. . Thalidomide, a potent agent for the treatment of graft-versus-host disease. Transplant Proc. 1986; 18: 904–906.

McCarthy D.M. , Kanfer E.J. , Barrett A.J. . Thalidomide for the therapy of graft-versus-host disease following allogeneic bone marrow transplantation. Biomed Pharmacother. 1989; 43: 693–697.

Heney D. , Bailey C.C. , Lewis I.J. . Thalidomide in the treatment of graft-versus-host disease. Biomed Pharmacother. 1990; 44: 199–204.

Heney D. , Norfolk D.R. , Wheeldon J. . Thalidomide treatment for chronic graft-versus-host disease. Br J Haematol. 1991; 78: 23–27.

Cole C.H. , Rogers P.C. , Pritchard S. . Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation. Bone Marrow Transplant. 1994; 14: 937–942.

Forsyth C.J. , Cremer P.D. , Torzillo P. . Thalidomide responsive chronic pulmonary GVHD. Bone Marrow Transplant. 1996; 17: 291–293.

Rovelli A. , Arrigo C. , Nesi F. . The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children. Bone Marrow Transplant. 1998; 21: 577–581.

Parker P.M. , Chao N. , Nademanee A. . Thalidomide as salvage therapy for chronic graft-vs-host disease. Blood. 1995; 86: 3604–3609.

Reyes-Teran G. , Sierra-Madero J.G. , Martinez del Cerro V. . Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial. AIDS. 1996; 10: 1501–1507.

Jacobson J.M. , Greenspan J.S. , Spritzler J. . Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. N Engl J Med. 1997; 336: 1487–1493.

Alexander L.N. , Wilcox C.M. . A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers. AIDS Res Hum Retroviruses. 1997; 13: 301–304.

D'Amato R.J. , Loughnan M.S. , Flynn E. . Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A. 1991; 91: 4082–4085.

Nguyen M. , Tran C. , Barsky S. . Thalidomide and chemotherapy combination: preliminary results of preclinical and clinical studies. Int J Oncol. 1997; 10: 965–969.

Costa P.T. , Leal RMLV , Morais L.O. . Thalidomide and pentoxifylline prevent the development of chronic cardiomyopathy provoked by doxorubicin in rats without inhibiting its antitumoral effect. Blood. 1998; 92(suppl 1, part 2): 235b.

Long G. , Vredenburgh J. , Rizziere D.A. . Pilot trial of thalidomide post-autologous peripheral blood progenitor cell transplantation in patients with metastatic breast cancer. Proc Annu Meet Am Soc Clin Oncol. 1998; 17: 181. Abstract.

Fine H.A. , Loeffler J.S. , Kyritsis A. . A phase II trial of the anti-angiogenic agent, thalidomide, in patients with recurrent high-grade gliomas. Proc Annu Meet Am Soc Clin Oncol. 1997; 16: 1372. Abstract.

Bower M. , Howard M. , Gracie F. . A phase II study of thalidomide for Kaposi's sarcoma: activity and correlation with KSHV DNA load. J AIDS Hum Retrovirol. 1997; 14(A35): 76. Abstract.

Politi P. , Reboredo G. , Losso M. . Phase I trial of thalidomide in AIDS-related Kaposi sarcoma. Proc Annu Meet Am Soc Clin Oncol. 1998; 17: 41. Abstract.

Yarchoan R. , Little R.F. , Wyvill K. . A phase II study of oral thalidomide in patients with AIDS-related Kaposi's sarcoma (KS). In: Proceedings of the 12th World AIDS Conference; 1998: 22280. Abstract.

Singhal S. , Mehta J. , Eddlemon P. . Marked anti-tumor effect from anti-angiogenesis therapy with thalidomide in high risk refractory multiple myeloma. Blood. 1998; 92(suppl 1, part 1): 318. Abstract.

Barlogie B. , Desikan R. , Munshi N. . Single course D.T.PACE anti-angiochemotherapy effects CR in plasma cell leukemia and fulminant multiple myeloma. Blood. 1998; 92(suppl 1, part 2): 273b. Abstract.

Figg W.D. , Bergan R. , Brawley . Randomized phase II study of thalidomide in androgen-independent prostate cancer. Proc Annu Meet Am Soc Clin Oncol. 1997; 16: 333. Abstract.

Dixon S.C. , Bauer K.S. , Zalles A. . Thalidomide effects on angiogenesis and PSA expression. Proc Annu Meet Am Assoc Cancer Res. 1997; 38: 2866.

Eisen T. , Boshoff C. , Vaughan M.M. . Anti-angiogenic treatment of metastatic melanoma, renal cell, ovarian and breast cancers with thalidomide: a phase II study. Proc Annu Meet Am Soc Clin Oncol. 1998; 17: 441. Abstract.

Marx G.M. , Levi J.A. , Bell D.R. . A phase I/II trial of thalidomide as an antiangiogenic agent in the treatment of advanced cancer. Proc Annu Meet Am Soc Clin Oncol. 1999; 18: 454. Abstract.

Thalomid (thalidomide) STEPS (System for Thalidomide Education and Prescribing Safety) Folder. Warren, NJ: Celgene Corp; 1998.

Bauer K. , Dixon S.C. , Figg W.D. . Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent. Biochem Pharmacol. 1998; 55: 1827–1834.

Celgene Corp Request for Medical Information. Thalomid and Multiple Myeloma. Document #703. Revised February 1999.

Figg W.D. , Raje S. , Bauer K.S. . Pharmacokinetics of thalidomide in an elderly prostate cancer population. J Pharm Sci. 1999; 88: 121–125.

Chao N.J. , Parker P.M. , Niland J.C. . Paradoxical effect of thalidomide prophylaxis on chronic graft-versus-host disease. Biol Blood Marrow Transplant. 1996; 2: 86–92.

Wolkenstein P. , Latarjet J. , Roujeau J.C. . Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet. 1998; 352: 1586–1589.

Celgene Corp Request for Medical Information. Thalomid and cancer. Document #702. Revised February 1999.

Oral contraceptives monograph. In: Drug Facts and Comparisons. St. Louis, Mo: Facts and Comparisons Inc; 1998: 107h.

Grabstald H. , Golbey R. . Clinical experiences with thalidomide in patients with cancer. Clin Pharmacol Ther. 1965; 6: 298–302.

Olson K. , Hall T. , Horton J. . Thalidomide in the treatment of advanced cancer. Clin Pharmacol Ther. 1965; 6: 292–297.

Gagnon B. , Bruera E. . A review of the drug treatment of cachexia associated with cancer. Drugs. 1998; 55: 675–688.

Deaner P. . Thalidomide for distressing night sweats in advanced malignant disease. Palliat Med. 1998; 12: 208–209.

Thalomid. Drug Topics Red Book. 103rd ed. Montvale, NJ: Medical Economics Co Inc; 1999: 564